---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-081874"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:23:30.051173+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical self-reports potential Nasdaq rule violation for share issuance

## Summary
- Company notified Nasdaq of possible violation of Listing Rule 5635(d)(2) regarding convertible-note conversion and warrant exercise.
- $9.8M convertible notes issued in four tranches with warrants equal to 25% of conversion amount per March 2023 SPA.
- Aug and Dec 2023 amendments added $2.2M notes each, reset conversion price to $0.20, and issued 4,765,620 (190,624 post-R/S) and 1,055,416 (42,216 post-R/S) additional warrants.
- Company requests Nasdaq determination; committed to full shareholder-approval compliance and adviser engagement.

## SEC filing metadata
- accession: 0000950170-24-081874
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017024081874/0000950170-24-081874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017024081874/icu-20240703.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-081874
- JSON: https://secwatch.observer/filing/0000950170-24-081874.json
- Plain text: https://secwatch.observer/filing/0000950170-24-081874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.